ID   AS-E2
AC   CVCL_6769
DR   Cosmic; 787421
DR   Cosmic; 975239
DR   Cosmic; 1012059
DR   Cosmic; 1281306
DR   Cosmic; 2306200
DR   RCB; RCB5257
DR   Wikidata; Q54750585
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9369430;
RX   PubMed=9419420;
RX   PubMed=16408098;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=AS-E2
CC   Population: Japanese.
CC   Characteristics: EPO dependent.
CC   Doubling time: ~49 hours (PubMed=9369430).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68693; Adult pure erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=9369430; DOI=10.1038/sj.leu.2400838;
RA   Miyazaki Y., Kuriyama K., Higuchi M., Tsushima H., Sohda H., Imai N.,
RA   Saito M., Kondo T., Tomonaga M.;
RT   "Establishment and characterization of a new erythropoietin-dependent
RT   acute myeloid leukemia cell line, AS-E2.";
RL   Leukemia 11:1941-1949(1997).
//
RX   PubMed=9419420;
RA   Tsushima H., Urata Y., Miyazaki Y., Fuchigami K., Kuriyama K.,
RA   Kondo T., Tomonaga M.;
RT   "Human erythropoietin receptor increases GATA-2 and Bcl-xL by a
RT   protein kinase C-dependent pathway in human erythropoietin-dependent
RT   cell line AS-E2.";
RL   Cell Growth Differ. 8:1317-1328(1997).
//
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.;
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).
//